{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T04:55:15Z","timestamp":1795064115618,"version":"4.10.2"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,2,21]],"date-time":"2020-02-21T00:00:00Z","timestamp":1582243200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,2,21]],"date-time":"2020-02-21T00:00:00Z","timestamp":1582243200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Musculoskelet Disord"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Seven\u2009T ultra-high field MRI systems have recently been approved for clinical use by the U.S. and European regulatory agencies. These systems are now being used clinically and will likely be more widely available in the near future. One of the applications of 7\u2009T systems is musculoskeletal disease and particularly peripheral arthritis imaging. Since the introduction of potent anti-rheumatic therapies over the last two decades MRI has gained increasing importance particularly for assessment of disease activity in early stages of several rheumatic disorders. Commonly gadolinium-based contrast agents are used for assessment of synovitis. Due to potential side-effects of gadolinium non-enhanced techniques are desirable that enable visualization of inflammatory disease manifestations. The feasibility of 7\u2009T MRI for evaluation of peripheral arthritis has not been shown up to now. Aim of our study was to evaluate the feasibility of contrast-enhanced (CE) and non-enhanced MRI at 7\u2009T for the assessment of knee joint synovitis.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Method<\/jats:title>\n<jats:p>Seven\u2009T MRI was acquired for 10 patients with an established diagnosis of psoriatic or rheumatoid arthritis. The study pulse sequence protocol was comprised of a sagittal intermediate-weighted fat-suppressed (FS), axial fluid-attenuated inversion recovery (FLAIR) FS, sagittal 3D T1-weighted dynamic contrast enhanced (DCE) and an axial static 2D T1-weighted FS contrast-enhanced sequence (T1-FS CE). Ordinal scoring on non-enhanced (Hoffa- and effusion-synovitis) and enhanced MRI (11-point synovitis score), and comparison of FLAIR-FS with static T1-FS CE MRI using semiquantitative (SQ) grading and volume assessment was performed. For inter- and intra-reader reliability assessment weighted kappa statistics for ordinal scores and intraclass correlation coefficients (ICC) for continuous variables were used.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>The total length of study protocol was 15\u2009min 38\u2009s. Different amounts of synovitis were observed in all patients (mild: <jats:italic>n<\/jats:italic>\u00a0=\u20093; moderate: <jats:italic>n<\/jats:italic>\u00a0=\u20095; severe: <jats:italic>n<\/jats:italic>\u00a0=\u20092). Consistently, SQ assessment yielded significantly lower peripatellar summed synovitis scores for the FLAIR-FS sequence compared to the CE T1-FS sequence (<jats:italic>p<\/jats:italic>\u00a0&lt;\u20090.01). FLAIR-FS showed significantly lower peripatellar synovial volumes (<jats:italic>p<\/jats:italic>\u00a0&lt;\u20090.01) compared to CE T1-FS imaging with an average percentage difference of 18.6\u2009\u00b1\u20099.5%. Inter- and intra-reader reliability for ordinal SQ scoring ranged from 0.21 (inter-reader Hoffa-synovitis) to 1.00 (inter-reader effusion-synovitis). Inter- and intra-observer reliability of SQ 3D-DCE parameters ranged from 0.86 to 0.99.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>Seven\u2009T FLAIR-FS ultra-high field MRI is a potential non-enhanced imaging method able to visualize synovial inflammation with high conspicuity and holds promise for further application in research endeavors and clinical routine by trained readers.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12891-020-3122-y","type":"journal-article","created":{"date-parts":[[2020,2,21]],"date-time":"2020-02-21T20:02:19Z","timestamp":1582315339000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Comprehensive assessment of knee joint synovitis at 7\u2009T MRI using contrast-enhanced and non-enhanced sequences"],"prefix":"10.1186","volume":"21","author":[{"given":"Christoph","family":"Treutlein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"B\u00e4uerle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armin M.","family":"Nagel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Guermazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnd","family":"Kleyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Schett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Hepp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Uder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9238-7350","authenticated-orcid":false,"given":"Frank W.","family":"Roemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,21]]},"reference":[{"key":"3122_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pnmrs.2018.06.001","volume":"109","author":"ME Ladd","year":"2018","unstructured":"Ladd ME, Bachert P, Meyerspeer M, Moser E, Nagel AM, Norris DG, et al. Pros and cons of ultra-high-field MRI\/MRS for human application. Prog Nucl Magn Reson Spectrosc. 2018;109:1\u201350.","journal-title":"Prog Nucl Magn Reson Spectrosc"},{"key":"3122_CR2","unstructured":"Unites States Food & Drug Administration. FDA News Release. FDA clears first 7T magnetic resonance imaging device. October 12, 2017. url: https:\/\/www.fda.gov\/NewsEvents\/Newsroom\/PressAnnouncements\/ucm580154.htm accessed May 12, 2019."},{"issue":"10","key":"3122_CR3","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/nrrheum.2014.145","volume":"10","author":"E Filippucci","year":"2014","unstructured":"Filippucci E, Di Geso L, Grassi W. Progress in imaging in rheumatology. Nat Rev Rheumatol. 2014;10(10):628\u201334.","journal-title":"Nat Rev Rheumatol"},{"issue":"5 Suppl 85","key":"3122_CR4","first-page":"S-17","volume":"32","author":"M Ostergaard","year":"2014","unstructured":"Ostergaard M, Moller-Bisgaard S. Optimal use of MRI in clinical trials, clinical care and clinical registries of patients with rheumatoid arthritis. Clin Exp Rheumatol. 2014;32(5 Suppl 85):S-17\u201322.","journal-title":"Clin Exp Rheumatol"},{"issue":"11","key":"3122_CR5","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1136\/annrheumdis-2017-211265","volume":"76","author":"JF Baker","year":"2017","unstructured":"Baker JF, Ostergaard M, Conaghan PG. Is MRI a predictive biomarker for clinical response to biologics in rheumatoid arthritis? Ann Rheum Dis. 2017;76(11):e45.","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"3122_CR6","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1002\/art.11076","volume":"48","author":"M Ostergaard","year":"2003","unstructured":"Ostergaard M, Hansen M, Stoltenberg M, Jensen KE, Szkudlarek M, Pedersen-Zbinden B, et al. New radiographic bone erosions in the wrists of patients with rheumatoid arthritis are detectable with magnetic resonance imaging a median of two years earlier. Arthritis Rheum. 2003;48(8):2128\u201331.","journal-title":"Arthritis Rheum"},{"issue":"6","key":"3122_CR7","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1136\/annrheumdis-2014-206934","volume":"75","author":"JF Baker","year":"2016","unstructured":"Baker JF, Conaghan PG, Emery P, Baker DG, Ostergaard M. Validity of early MRI structural damage end points and potential impact on clinical trial design in rheumatoid arthritis. Ann Rheum Dis. 2016;75(6):1114\u20139.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"3122_CR8","first-page":"1385","volume":"30","author":"M Ostergaard","year":"2003","unstructured":"Ostergaard M, Peterfy C, Conaghan P, McQueen F, Bird P, Ejbjerg B, et al. OMERACT rheumatoid arthritis magnetic resonance imaging studies. Core set of MRI acquisitions, joint pathology definitions, and the OMERACT RA-MRI scoring system. J Rheumatol. 2003;30(6):1385\u20136.","journal-title":"J Rheumatol"},{"issue":"2","key":"3122_CR9","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.joca.2016.09.016","volume":"25","author":"MD Crema","year":"2017","unstructured":"Crema MD, Roemer FW, Li L, Alexander RC, Chessell IP, Dudley AD, et al. Comparison between semiquantitative and quantitative methods for the assessment of knee synovitis in osteoarthritis using non-enhanced and gadolinium-enhanced MRI. Osteoarthr Cartil. 2017;25(2):267\u201371.","journal-title":"Osteoarthr Cartil"},{"issue":"10","key":"3122_CR10","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/j.joca.2010.07.008","volume":"18","author":"FW Roemer","year":"2010","unstructured":"Roemer FW, Kassim Javaid M, Guermazi A, Thomas M, Kiran A, Keen R, et al. Anatomical distribution of synovitis in knee osteoarthritis and its association with joint effusion assessed on non-enhanced and contrast-enhanced MRI. Osteoarthr Cartil. 2010;18(10):1269\u201374.","journal-title":"Osteoarthr Cartil"},{"issue":"1","key":"3122_CR11","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1007\/s00330-014-3351-2","volume":"25","author":"IM Noebauer-Huhmann","year":"2015","unstructured":"Noebauer-Huhmann IM, Szomolanyi P, Kronnerwetter C, Widhalm G, Weber M, Nemec S, et al. Brain tumours at 7T MRI compared to 3T--contrast effect after half and full standard contrast agent dose: initial results. Eur Radiol. 2015;25(1):106\u201312.","journal-title":"Eur Radiol"},{"issue":"7","key":"3122_CR12","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1097\/RLI.0b013e31820e1467","volume":"46","author":"L Umutlu","year":"2011","unstructured":"Umutlu L, Kraff O, Orzada S, Fischer A, Kinner S, Maderwald S, et al. Dynamic contrast-enhanced renal MRI at 7 tesla: preliminary results. Investig Radiol. 2011;46(7):425\u201333.","journal-title":"Investig Radiol"},{"issue":"3","key":"3122_CR13","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1148\/radiol.15150025","volume":"275","author":"RJ McDonald","year":"2015","unstructured":"McDonald RJ, McDonald JS, Kallmes DF, Jentoft ME, Murray DL, Thielen KR, et al. Intracranial gadolinium deposition after contrast-enhanced MR imaging. Radiology. 2015;275(3):772\u201382.","journal-title":"Radiology"},{"issue":"2","key":"3122_CR14","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s00330-017-5017-3","volume":"28","author":"YN Son","year":"2018","unstructured":"Son YN, Jin W, Jahng GH, Cha JG, Park YS, Yun SJ, et al. Efficacy of double inversion recovery magnetic resonance imaging for the evaluation of the synovium in the femoro-patellar joint without contrast enhancement. Eur Radiol. 2018;28(2):459\u201367.","journal-title":"Eur Radiol"},{"issue":"3","key":"3122_CR15","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1148\/radiol.2016160155","volume":"283","author":"HJ Yoo","year":"2017","unstructured":"Yoo HJ, Hong SH, Oh HY, Choi JY, Chae HD, Ahn JM, et al. Diagnostic accuracy of a fluid-attenuated inversion-recovery sequence with fat suppression for assessment of Peripatellar Synovitis: preliminary results and comparison with contrast-enhanced MR imaging. Radiology. 2017;283(3):769\u201378.","journal-title":"Radiology."},{"issue":"6","key":"3122_CR16","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s10334-015-0499-y","volume":"28","author":"Y Noureddine","year":"2015","unstructured":"Noureddine Y, Bitz AK, Ladd ME, Thurling M, Ladd SC, Schaefers G, et al. Experience with magnetic resonance imaging of human subjects with passive implants and tattoos at 7 T: a retrospective study. MAGMA. 2015;28(6):577\u201390.","journal-title":"MAGMA"},{"issue":"8","key":"3122_CR17","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1016\/j.joca.2011.05.004","volume":"19","author":"DJ Hunter","year":"2011","unstructured":"Hunter DJ, Guermazi A, Lo GH, Grainger AJ, Conaghan PG, Boudreau RM, et al. Evolution of semi-quantitative whole joint assessment of knee OA: MOAKS (MRI osteoarthritis knee score). Osteoarthr Cartil. 2011;19(8):990\u20131002.","journal-title":"Osteoarthr Cartil"},{"issue":"5","key":"3122_CR18","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1136\/ard.2010.139618","volume":"70","author":"A Guermazi","year":"2011","unstructured":"Guermazi A, Roemer FW, Hayashi D, Crema MD, Niu J, Zhang Y, et al. Assessment of synovitis with contrast-enhanced MRI using a whole-joint semiquantitative scoring system in people with, or at high risk of, knee osteoarthritis: the MOST study. Ann Rheum Dis. 2011;70(5):805\u201311.","journal-title":"Ann Rheum Dis"},{"key":"3122_CR19","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2307\/2529310","volume":"33","author":"JR Landis","year":"1977","unstructured":"Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159\u201374.","journal-title":"Biometrics"},{"key":"3122_CR20","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jcm.2016.02.012","volume":"15","author":"TK Koo","year":"2016","unstructured":"Koo TK, Mae YL. A guideline of selecting and reporting intraclass correlation coeffiecients for realibility research. J Chiropr Med. 2016;15:155\u201363.","journal-title":"J Chiropr Med"},{"issue":"9","key":"3122_CR21","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1002\/nbm.3272","volume":"29","author":"S Trattnig","year":"2016","unstructured":"Trattnig S, Bogner W, Gruber S, Szomolanyi P, Juras V, Robinson S, et al. Clinical applications at ultrahigh field (7 T). Where does it make the difference? NMR Biomed. 2016;29(9):1316\u201334.","journal-title":"NMR Biomed"},{"issue":"2","key":"3122_CR22","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1148\/radiol.13131725","volume":"271","author":"AM Nagel","year":"2014","unstructured":"Nagel AM, Lehmann-Horn F, Weber MA, Jurkat-Rott K, Wolf MB, Radbruch A, et al. In vivo 35Cl MR imaging in humans: a feasibility study. Radiology. 2014;271(2):585\u201395.","journal-title":"Radiology."},{"issue":"2","key":"3122_CR23","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1002\/nbm.3280","volume":"29","author":"S Zbyn","year":"2016","unstructured":"Zbyn S, Mlynarik V, Juras V, Szomolanyi P, Trattnig S. Evaluation of cartilage repair and osteoarthritis with sodium MRI. NMR Biomed. 2016;29(2):206\u201315.","journal-title":"NMR Biomed"},{"issue":"2","key":"3122_CR24","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3109\/03009742.2011.608375","volume":"41","author":"MB Axelsen","year":"2012","unstructured":"Axelsen MB, Stoltenberg M, Poggenborg RP, Kubassova O, Boesen M, Bliddal H, H\u00f8rslev-Petersen K, Hanson LG, \u00d8stergaard M. Dynamic gadolinium-enhanced magnetic resonance imaging allows accurate assessment of the synovial inflammatory activity in rheumatoid arthritis knee joints: a comparison with synovial histology. Scand J Rheumatol. 2012;41(2):89\u201394.","journal-title":"Scand J Rheumatol"},{"issue":"5","key":"3122_CR25","doi-asserted-by":"publisher","first-page":"3056","DOI":"10.1002\/mrm.27633","volume":"81","author":"TA Perry","year":"2019","unstructured":"Perry TA, Gait A, O'Neill TW, Parkes MJ, Hodgson R, Callaghan MJ, Arden NK, Felson DT, Cootes TF. Measurement of synovial tissue volume in knee osteoarthritis using a semiautomated MRI-based quantitative approach. Magn Reson Med. 2019;81(5):3056\u201364.","journal-title":"Magn Reson Med"},{"issue":"5","key":"3122_CR26","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.1118\/1.3581060","volume":"38","author":"GH Jahng","year":"2011","unstructured":"Jahng GH, Jin W, Yang DM, Ryu KN. Optimization of a double inversion recovery sequence for noninvasive synovium imaging of joint effusion in the knee. Med Phys. 2011;38(5):2579\u201385.","journal-title":"Med Phys"},{"issue":"9","key":"3122_CR27","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1097\/RLI.0b013e3181ebd4e3","volume":"45","author":"IM Noebauer-Huhmann","year":"2010","unstructured":"Noebauer-Huhmann IM, Szomolanyi P, Juras V, Kraff O, Ladd ME, Trattnig S. Gadolinium-based magnetic resonance contrast agents at 7 tesla: in vitro T1 relaxivities in human blood plasma. Investig Radiol. 2010;45(9):554\u20138.","journal-title":"Investig Radiol"},{"issue":"1","key":"3122_CR28","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s00256-011-1112-8","volume":"41","author":"M Navalho","year":"2012","unstructured":"Navalho M, Resende C, Rodrigues AM, Gaspar A, Fonseca JE, Canhao H, et al. Dynamic contrast-enhanced 3-T magnetic resonance imaging: a method for quantifying disease activity in early polyarthritis. Skelet Radiol. 2012;41(1):51\u20139.","journal-title":"Skelet Radiol"}],"container-title":["BMC Musculoskeletal Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-020-3122-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12891-020-3122-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-020-3122-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,21]],"date-time":"2021-02-21T00:51:20Z","timestamp":1613868680000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmusculoskeletdisord.biomedcentral.com\/articles\/10.1186\/s12891-020-3122-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,21]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["3122"],"URL":"https:\/\/doi.org\/10.1186\/s12891-020-3122-y","relation":{},"ISSN":["1471-2474"],"issn-type":[{"value":"1471-2474","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,21]]},"assertion":[{"value":"29 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Written informed consent was obtained for this ethics board-approved investigation (Local IRB number: AZ_189_15B). (Ethics committee of the Friedrich-Alexander University Erlangen-N\u00fcrnberg).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Dr. Guermazi has received consultancies, speaking fees, and\/or honoraria from Sanofi-Aventis, Merck Serono, and TissuGene and is President and shareholder of Boston Imaging Core Lab (BICL), LLC a company providing image assessment services. Dr. Roemer is Chief Medical Officer and shareholder of BICL, LLC. None of the other authors have declared any competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"116"}}